Familial aggregation of prostate cancer has been demonstrated in studies conducted in a number of countries prior to the widespread adoption of prostate-specific antigen (PSA) testing for prostate cancer detection. PSA testing leads to over-diagnosis of asymptomatic disease that may not have become clinically significant within a man’s normal lifetime. This increase in the number of asymptomatic men diagnosed might alter the magnitude of familial risk estimates and the importance of a prostate cancer family history. (For complete abstract open document)
| Identifer | oai:union.ndltd.org:ADTP/245738 |
| Creators | Staples, Margaret Patricia |
| Source Sets | Australiasian Digital Theses Program |
| Language | English |
| Detected Language | English |
| Rights | Terms and Conditions: Copyright in works deposited in the University of Melbourne Eprints Repository (UMER) is retained by the copyright owner. The work may not be altered without permission from the copyright owner. Readers may only, download, print, and save electronic copies of whole works for their own personal non-commercial use. Any use that exceeds these limits requires permission from the copyright owner. Attribution is essential when quoting or paraphrasing from these works., Open Access |
Page generated in 0.0018 seconds